Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has informed that it has enclosed a Press Release on 22nd June 2021, titled ‘Sun Pharma Announces Settlement of Patent Litigation for Generic Revlimid® (lenalidomide) in US’ relating to settlement of patent litigation for generic Revlimid® (lenalidomide) in the US which the company shall be releasing after sending this letter.

The above information is a part of company’s filings submitted to BSE.